TFS
AMPE

Thoroughbred Financial Services’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Thoroughbred Financial Services’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-44
Closed -$7K – 389
2021
Q4 		$7K Buy
+44
New +$16.4K ﹤0.01% 336
2021
Q3 		– Sell
-44
Closed -$22K – 331
2021
Q2 		$22K Buy
+44
New +$23.6K 0.01% 300

Other funds holding AMPE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
WIC
Willis Investment Counsel Gainesville, Georgia $1.83B AUM 15.78% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
WWM
Western Wealth Management Golden, Colorado $2.63B AUM 21.3% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return

Thoroughbred Financial Services's AMPE Position: Q1 2022 in Review

Thoroughbred Financial Services sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q1 2022, closing a stake of 44 shares — an estimated $7K sold.

Thoroughbred Financial Services first reported a position in AMPE in Q2 2021 and held it in 2 quarters. The position peaked at $22K in Q2 2021. 128 funds tracked by Wall St. Rank hold AMPE as of Q1 2022.

  • Thoroughbred Financial Services reported no remaining Ampio Pharmaceuticals Inc. position as of Q1 2022 after selling out during the quarter.
  • Thoroughbred Financial Services sold 44 Ampio Pharmaceuticals Inc. shares in Q1 2022, an estimated $7K.
  • Thoroughbred Financial Services first reported a position in Ampio Pharmaceuticals Inc. in Q2 2021 and held it in 2 quarters.
  • Thoroughbred Financial Services's Ampio Pharmaceuticals Inc. position peaked at $22K in Q2 2021.
  • 128 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q1 2022.

Based on Thoroughbred Financial Services's 13F filing for Q1 2022, filed 4 May 2022.